News
The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...
The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug ...
The recent approval of weight-loss drug Wegovy in New Zealand has been hyped as a breakthrough in the country’s fight against ...
47m
Stocktwits on MSNHims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent ExpiresHims & Hers Health, Inc. (HIMS) announced on Wednesday that it will expand to Canada next year with its weight loss program, ...
ASA said the advert posted to her Instagram, which is still live, would 'likely' encourage people to 'request the ...
U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...
The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...
2h
Zacks Investment Research on MSNIs Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...
A $4.4 million shortfall in the city’s health insurance trust fund is a result of rising medical costs, including from the classification of drugs that include weight loss ...
A MOUNJARO user has candidly opened up on what happened after she used fat jabs for just four weeks. Despite being “really happy” with losing two to three lbs a week on the injections, Megan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results